Barlow Carrolee 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Common Stock
2023-02-22+3,882→ 13,315 total - Disposition to Issuer
Restricted Stock Units
2023-02-22−3,882→ 0 total→ Common Stock (3,882 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023.